TECH
BIO-TECHNE Corp
NASDAQ · Healthcare · Biotechnology · US
$72.69
−0.03%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+0.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 30, 2026 | HIGGINS JOHN L · director | F-InKind | 5,562 | $73 |
| Sep 30, 2026 | HIGGINS JOHN L · director | M-Exempt | 15,940 | $0.00 |
| Sep 24, 2026 | BAUMGARTNER ROBERT V · director | M-Exempt | 15,940 | $0.00 |
| Sep 24, 2026 | BAUMGARTNER ROBERT V · director | F-InKind | 5,559 | $73 |
| Aug 19, 2026 | Hippel James · officer: CFO | A-Award | 36,459 | $0.00 |
| Aug 19, 2026 | Crouse Steven C. · officer: President - Diag & Spatial Bi | A-Award | 14,140 | $0.00 |
| Aug 19, 2026 | Kelderman Kim · director, officer: Chief Executive Officer | A-Award | 93,582 | $0.00 |
| Aug 19, 2026 | Geist William · officer: PRESIDENT, PROTEIN SCIENCES | A-Award | 14,762 | $0.00 |
| Aug 19, 2026 | Hippel James · officer: CFO | A-Award | 22,438 | $0.00 |
| Aug 19, 2026 | Bohnen Shane · officer: SVP - General Counsel | A-Award | 18,432 | $0.00 |
| Aug 19, 2026 | Bohnen Shane · officer: SVP - General Counsel | A-Award | 11,344 | $0.00 |
| Aug 19, 2026 | Herr Amy E. · director | A-Award | 1,381 | $0.00 |
| Aug 19, 2026 | Crouse Steven C. · officer: President - Diag & Spatial Bi | A-Award | 8,702 | $0.00 |
| Aug 19, 2026 | Kelderman Kim · director, officer: Chief Executive Officer | A-Award | 57,590 | $0.00 |
| Aug 19, 2026 | Geist William · officer: PRESIDENT, PROTEIN SCIENCES | A-Award | 23,985 | $0.00 |
| Aug 18, 2026 | Geist William · officer: PRESIDENT, PROTEIN SCIENCES | M-Exempt | 2,623 | $0.00 |
| Aug 18, 2026 | Bohnen Shane · officer: SVP - General Counsel | M-Exempt | 300 | $0.00 |
| Aug 18, 2026 | Bohnen Shane · officer: SVP - General Counsel | M-Exempt | 49 | $0.00 |
| Aug 18, 2026 | Herr Amy E. · director | M-Exempt | 118 | $0.00 |
| Aug 18, 2026 | Geist William · officer: PRESIDENT, PROTEIN SCIENCES | M-Exempt | 567 | $0.00 |
| Aug 18, 2026 | Herr Amy E. · director | F-InKind | 213 | $72 |
| Aug 18, 2026 | Crouse Steven C. · officer: President - Diag & Spatial Bi | F-InKind | 1,947 | $72 |
| Aug 18, 2026 | Bohnen Shane · officer: SVP - General Counsel | F-InKind | 1,343 | $72 |
| Aug 18, 2026 | Crouse Steven C. · officer: President - Diag & Spatial Bi | M-Exempt | 1,868 | $0.00 |
| Aug 18, 2026 | Bohnen Shane · officer: SVP - General Counsel | M-Exempt | 4,350 | $0.00 |
| Aug 18, 2026 | Hippel James · officer: CFO | F-InKind | 4,310 | $72 |
| Aug 18, 2026 | Herr Amy E. · director | M-Exempt | 160 | $0.00 |
| Aug 18, 2026 | Kelderman Kim · director, officer: Chief Executive Officer | F-InKind | 10,821 | $72 |
| Aug 18, 2026 | Hippel James · officer: CFO | M-Exempt | 9,779 | $0.00 |
| Aug 18, 2026 | Herr Amy E. · director | M-Exempt | 589 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 210Increased 343Reduced 469Sold out 114
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 14,025,816 | Aug 7, 2026 |
| FMR LLC | Increased | 12,794,784 | Aug 13, 2026 |
| BLACKROCK, INC. | Increased | 12,264,513 | May 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 10,218,558 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 10,179,709 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 8,532,873 | May 15, 2026 |
| FMR LLC | Increased | 7,899,928 | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 7,343,324 | Aug 14, 2026 |
| HBK INVESTMENTS L P | New Position | 6,825,000 | Sep 16, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 6,506,360 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 6,480,337 | May 8, 2026 |
| MORGAN STANLEY | Reduced | 6,374,717 | Aug 13, 2026 |
| STATE STREET CORP | Increased | 5,980,370 | Sep 22, 2026 |
| STATE STREET CORP | Increased | 5,868,396 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 5,351,464 | Aug 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 30, 2026